Position in NSRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$299,191
New position
Shares Held
134,771
first reported quarter
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 9 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $179,007,948 across 10 Drug Manufacturers - General names. NSRX ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,004 | $61,628,269 | |
| 2 | JNJ |
Johnson & Johnson
|
164,590 | $40,232,379 | |
| 3 | BIIB |
Biogen Inc.
|
201,367 | $36,916,612 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
100,010 | $13,938,393 | |
| 5 | MRK |
Merck & Co., Inc.
|
101,505 | $12,210,036 | |
| 6 | NVO |
Novo Nordisk A S
|
125,038 | $4,595,146 | |
| 7 | ABBV |
AbbVie Inc.
|
20,010 | $4,351,974 | |
| 8 | PFE |
Pfizer Inc
|
90,000 | $2,527,200 |
All Filings in NSRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $299,191 | 134,771 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||